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1. Introduction 
Diabetes mellitus is a growing public health affecting people worldwide both in developing 
and developed countries, and poses a major socio-economic challenge [1], [2]. A chronic 
metabolic disorder of multiple aetiologies is assuming epidemic proportions worldwide [3]. 
It is also a complex disorder with profound consequences both acute and chronic. Genetic 
and environmental factors play a role in the development of the disease [4]. The cells of the 
body cannot metabolise sugar properly due to a total or relative lack of insulin. The body 
then breaks down its own fat, protein, and glycogen to produce sugar resulting in high 
sugar levels in the blood with excess by products called ketones being produced by the liver 
[5]. Diabetes causes disease in many organ systems, the severity of which may be related to 
how long the disease has been present and how well it has been controlled. The term 
diabetes mellitus describes a metabolic disorder of multiple aetiology characterised by 
chronic hyperglycaemia with disturbances of carbohydrate, fat, and protein metabolism 
resulting from defects in insulin secretion, insulin action or both [6],[7],[8],[9]. 
Diabetes mellitus may present with characteristic symptoms such as thirst, polyuria, 
blurring of vision and weight loss [6]. The abnormalities of carbohydrate, fat, and protein 
metabolism are due to deficient action of insulin on target tissues resulting from 
insensitivity or lack of insulin [6]. 
The effects of diabetes mellitus include long-term damage, dysfunction, and failure of 
various organs [6]. Type 1 diabetes mellitus encompasses the majority of diabetes, which are 
primarily due to pancreatic islet beta cell destruction and are prone to ketoacidosis [9]. If 
diabetes is not taken care of, complications such as heart, kidney, and eye diseases, 
incurable wounds leading to amputations of the extremities and mental disorders follow. 
Besides this, diabetes related complications inevitably cause high cost of treatment and 
opportunities for the concerned people and their families especially for poor families the 
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disease and its complications cause severe economical burden. In developing countries, non-
communicable diseases are evolving rapidly [8]. Diabetes mellitus places serious constraint 
on patients’ activities [10]. Despite the high prevalence, serious long-term complications, 
and established evidence based guidelines for management of diabetes mellitus, the quality 
of care is still deficient in developing countries [11]. Diabetes mellitus is emerging as an 
epidemic all over the world, represents an important public health problem, and is of 
clinical concern [12], [13], [14]. Type 1 diabetes has been estimated to affect approximately 
19,000 people in the worlds poorest countries but there is lack of good data on the disease 
prevalence in developing countries and in particular in sub-Saharan Africa[15]. 
Non-communicable disease such as diabetes mellitus, cardiovascular disease (especially 
ischaemic heart diseases and hypertension), stroke, cancer and chronic kidney and 
respiratory diseases have become the leading causes of mortality both in developed and 
developing nations of the world. The rising prevalence of these diseases is thought to be due 
to adoption of western lifestyles and urbanization [16]. With the current trend of transition 
from communicable to non-communicable diseases, it is projected that the later will equal or 
even exceed the former in developing nations thus culminating in double burden [17]. There 
is need for health care providers to intensify efforts in educating people living with type 2 
diabetes about good personal and environmental hygiene. Emphasis is on early diagnosis of 
diabetes, good glycaemic and blood control and proper education, programmes for health 
workers caring for diabetic patients as well as public awareness talks [17]. The prevalence of 
diabetes mellitus varies between different countries. Diabetes mellitus is defined as a 
chronic disorder, which is characterised by an elevated level of glucose in the blood due 
primarily in inadequate secretion or utilization of insulin [18]. 
Gestational diabetes mellitus is pregnancy induced diagnosed typically in the second half of 
pregnancy. It occurs when beta cells reserve is unable to counter balance the insulin 
resistance caused by placental hormone. Systemic hypertension and diabetes mellitus are 
common chronic conditions that frequently coexist and can significantly affect the health 
care needs and clinical outcome of affected individuals [19]. 
The excess global mortality attributable to diabetes in the year 2000 was estimated to be 2.9 
million deaths, equivalent to 5.2% of all deaths. Excess mortality attributable to diabetes 
accounted for 2-3 % of deaths in poorest countries [20]. Diabetes is a serious illness with 
multiple complications and premature mortality accounting for at least 10 % of total health 
care expenditure in many countries. Diabetes is often perceived as a disease of affluent 
countries. A serious chronic disease leads to a substantial reduction in life expectancy, 
decreased quality of life and increased costs of care [21]. 
Management of diabetes mellitus is multidisciplinary and this is not readily available in low 
resource settings. Dietary management is essential in the treatment and it alone may be 
adequate to achieve and maintain the therapeutic goals to normoglycaemia and 
normolipidaemia [22]. The care for diabetic patients includes a change in their life style, 
where the diet plan represents an important pillar of care so they can meet their goals. The 
management of people with diabetes mellitus is complex and good control significantly 
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reduces the risk of complications yet studies from around the world concisely demonstrate 
inappropriate variations in care [23]. 
2. Burden of diabetes mellitus in developing countries 
Sub-Saharan Africa will face a double disease burden represented by increased rates of non-
communicable diseases added to endemic, pandemic, and emergent infections such as 
malaria, tuberculosis, and HIV/AIDS. There is dearth of African data concerning the 
prevalence of type 1 diabetes mellitus [7]. Diabetes mellitus related cardiovascular disease 
complications are considered rare in Africa but are on the rise and are regularly associated 
with classic cardiovascular risk factors [24]. A missionary physician stated in 1901 that 
diabetes was very uncommon in the central region of Africa[25]. There is increased number 
of people suffering from non communicable diseases and this have been linked to unhealthy 
ways of living and lifestyle such as consumption of excess calories and reduction in the level 
of physical activities with the consequent development of obesity and insulin resistance [16]. 
Obesity, type 2 diabetes mellitus, and their associated long-term complications are emerging 
as critical, worldwide public health problems. Although few groups have been spared 
increased in the burden of these conditions, those undergoing rapid westernization, with the 
transition in diet and activity profiles have been especially affected. Among the most 
affected groups are those in Africa and the African Diaspora including the Caribbean, 
Europe, and North America [26]. The probably cause of obesity in developing countries has 
been attributed to the current lifestyle, where urbanization, better economic development 
and an increase in income have resulted in diet changes and less physical activity. The care 
for diabetic patients includes a change in their life style, where the diet plan represents an 
important pillar of care so they can meet their goals. Obesity increases the risk of developing 
not only type 2 diabetes, cardiovascular disease, stroke, osteoarthritis and some forms of 
cancer [27]. Obesity has been clearly linked with diabetic patients from all the major ethnic 
regions in Nigeria [16]. Over the past century, diabetes was considered a rare medical 
condition in Africa. However epidemiological studies carried out in the 90’s have provided 
evidence of a different picture[28]. The number of people with diabetes is increasing due to 
population growth, aging, diet, lifestyle, urbanization, and increased prevalence of obesity 
and physical activity [12], [28], [29]. Diet and lifestyle are the biggest culprits at least in the 
case of type 2 diabetes but genetics also have a role to play. Although obesity is an 
important factor in the diabetes epidemic, it does not alone explain the vast increase in 
prevalence especially in the developing world [29]. 
In developing countries, the majority of individuals with diabetes are aged between 45 and 
65 years while in developed countries, the majority are older than 64 years. Based on 
demographic changes by 2030, the number of people older than 64 years with diabetes will 
be more than 82 million in developing countries and more than 48 million in developed 
countries. The greatest relative increases are expected to occur in the Middle East crescent, 
sub-Saharan Africa and India [30]. Some 170 million men and women, who will reside in 
developing regions of the world in less than 30 years from now, will be suffering from 
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diabetes in their reproductive years of life [31]. In 2003, 194 million people 20 to 79 years of 
age had diabetes mellitus, almost three quarter of them are living in the developing world. 
Almost one million people die because of diabetes each year with two-thirds in developing 
countries. This growing problem will have a significant impact on national and individual 
economies as well individual health. However, it has proven difficult to determine just what 
that impact is [32]. Diabetes is an increasing problem in sub-Saharan Africa [33]. It is 
predicted that the prevalence of diabetes mellitus in adults will increase in the next two 
decades and much of the increase will occur in developing countries where the majority of 
patients are aged between 45 and 65 years. The incidence and prevalence of diabetes 
mellitus has continued to increase globally, despite a great deal of research with the 
resulting burden resting more heavily on tropical developing countries [17], [34]. Traditional 
rural communities still have very low prevalence at most 1-2% except in some specific high-
risk groups, whereas 1-3% or more adults in urban communities have diabetes. The 
combination of the rising prevalence of diabetes and the high rate of long-term 
complications in Africa will lead to a drastic increase of the burden of diabetes on health 
systems of African countries [34] and may have a devastating human and economic toll if 
the trends remain unabated [35]. In comparison to previous estimates from sub-Saharan 
Africa, the prevalence of adult onset diabetes seems to be on the increase[36]. 
In the last decade, diabetes has become a health problem in developing countries and has 
been found in a wide variety of atypical forms. Its burden is huge in developing countries 
due to lack of basic means for reaching diagnosis and a reasonable glycaemic control. The 
prevalence of type 1 diabetes mellitus varies from country to country in the African sub-
region. The low number of health care providers with the requisite knowledge, expertise, 
and experience in the care of children with diabetes is another major issue. Diabetes care in 
developing countries needs to address the specific background of the patient population, 
their needs, medical problems, and social constraints [35]. The region of sub-Saharan Africa 
contains 33 of the 50 poorest countries in the world and will experience the greatest risk in 
the prevalence of diabetes over the next 20 years [36]. 
Most African studies are hospital based and give data on patients that visit the hospital 
only. Type 1 diabetes has been estimated to affect approximately 19000 people in the 
world’s poorest countries but there is lack of good data on the disease prevalence in 
developing countries and in particular in sub-Saharan Africa [15]. The present increase in 
the rate of both type 2 diabetes mellitus and type 1 diabetes mellitus indicate the great and 
urgent need for more epidemiological surveys in sub-Saharan Africa. Such a need is dictated 
by the prevalence of undiagnosed diabetes mellitus [7].  
The prevalence of diabetes mellitus has significantly increased over recent decades in Tunisia 
to around 10% [37]. From various African studies in 6299 Africans aged 15 years and above in 
six Tanzanian villages, 0.87% had diabetes 1.1% males and 0.68% females [38]. In several 
Nigerian studies a prevalence of 1.6% in two suburban populations in northern Nigeria [39], 
1.4% in a rural population in Kwara State [40], 1.6/1000 in children in Sagamu [41], 1.2/1000 in 
children in Port Harcourt, southern Nigeria [42], case fatality in of 3.4% in Ekiti [43], 17.2% in 
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adults in Port Harcourt [44]. Diabetes was the sixth leading cause of admissions in Enugu, 
8.8% admissions into the medical wards at the university of Nigeria teaching hospital with a 
case fatality of 24% [45] and the leading cause of medical admissions in Nnewi, south east 
Nigeria [46]. In another Nigerian study in Dakace village about 10 km from Zaria, Zaria 2.0% 
and all the detected diabetics were males and above 45 years [1]. It was estimated that about 
100,000 children less than 15 years developed type 1 diabetes mellitus with wide global 
variations in incidence rates. There are scanty data on the incidence, aetiology, and outcome 
of children diabetes mellitus from developing countries like Nigeria [4]. It is also one of the 
commonest reasons for medical admissions and death in Nigerian hospitals. The disease 
burden of diabetes mellitus in developing countries is unacceptably high thus necessitating 
an indebt look at the management techniques and patients’ self-care habits due to the burden 
of diabetes care and the attendant complications, it affects all aspects of the society, and it has 
become a public health concern globally [47]. The increase in diabetes mellitus in Africa has 
been attributable in part to urbanization, urban residence, acculturation, abdominal obesity, 
globalization, westernization, sedentary lifestyle, behavioural habits, systemic arterial 
hypertension, physical inactivity, low intake of fruits and vegetables, high intake of animal 
fat and protein, industrialization, health transition, lifestyle changes, and the adoption of 
western lifestyle [1], [7], [47]. Variations in the type and epidemiology of diabetes between 
urban and rural areas have also been noted in Africa [47]. For a long-time, Africa was 
considered safe from many of the diseases that are called “diseases of affluence” which 
plague the western world. Similarly, there was a time when Africa was thought to be a 
continent relatively free of diabetes mellitus illness [48]. The disorder was previously thought 
to be rare or undocumented in rural Africa but over the past few decades, it has emerged as 
an important non-communicable disease in sub-Saharan Africa [2]. There is increased 
prevalence of diabetes in developing countries [47]. The high incidence of undiagnosed 
diabetics poses a major public health challenge in developing countries.  
3. Challenges and problems of managing diabetes mellitus in developing 
and poor resource countries 
3.1. Ignorance  
There is poor health seeking behaviours in low resource countries because of inaccessible 
quality health care. Poor health seeking behaviour results in late presentation and is a 
possible reason why majority of patients in these setting present with complications [14]. For 
diabetic children, it is possible that some of the affected children succumbed to the illness at 
home out of parental ignorance and high cost of orthodox medical care. It has been found 
that some patient sign against medical advice [4]. Some because of finance, others to seek 
alternative therapy or spiritual help. In a study on childhood diabetes in Kano, northwest 
Nigeria, three parents/guardians signed against medical advice. They belonged to the lower 
socioeconomic groups, and their management was largely hindered by lack of funds for 
investigations and drug procurement [4]. For people with diabetes living at or below the 
poverty level, the purchase of appropriate footwear may not be feasible or of high priority, 
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(bare foot walking is a common practice in rural communities but may be culturally 
influenced as well) [49]. Due to this ignorance and poverty, patients present late even with 
diabetic complications. Patients with diabetic foot continue to insist on medical management 
to salvage the affected limb until they become surgical emergencies [50]. Such emergency 
cases come with very little health reserve and clinical information to permit anaesthesia and 
surgery. The urgent need to save life then becomes the only support to favour surgical 
intervention. Any delay to allow for more time than necessary for basic investigations, 
remarkably influences the outcome of the procedures. Diabetics undergoing surgery belong 
to the high-risk group of patients and the risks are worst in the presence of severe 
complications such as diabetic foot gangrene [50]. 
3.2. Economic and cost of management of diabetes mellitus 
The cost of management of diabetes mellitus is complex and multidisciplinary therefore 
expensive in poor resource countries where majority of the population live below a dollar 
per day. Diabetes mellitus exacts three broad categories of economic costs. 
a. Direct costs on health care: This includes costs on purchase of medications, and 
glucometers for those that can afford it. Also the cost on visits to the health care facility 
and to see the professionals both general and specialist and money spent on 
hospitalisation both for the diabetes and diabetic complications [29]. 
b. Indirect health care costs: These include care of nursing homes and informal care by 
relatives and carers. Societal expectations about the appropriate place for professional 
and informal care certainly have important economic consequences [29]. Relatives and 
friends who care for the patient, may loose productive hours at their work or business. 
c. Productivity costs: This includes the loss of earnings from mortality and morbidity that 
is time taken by otherwise economic individuals with diabetes to treat their condition 
and disability associated with diabetes and its complications [29]. In developing 
countries with scarce resources, it is still possible to put in place effective programs to 
combat diabetes. Some patients in developing countries travel great distances to 
medical care facilities, which meant that greater earnings needed to be sacrificed in 
order to attend to medical visits and check-up. This discourages individuals from 
seeking an early diagnosis and is loss lost to follow up [29]. 
This growing problem of diabetes mellitus will have significant impact on national and 
individual economies as well as on individual health. The indirect costs of diabetes such as 
lost productivity are at least as high and increased as more economically productive people 
are affected [32]. Good data on the direct medical costs of diabetes are not available for most 
developing countries [32]. 
3.3. Poverty 
Health conditions in most African countries are poor and a large percentage of families live 
below the poverty line of one United States dollar per month [35]. Access to health services 
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is limited and living conditions are poor. The low number of health care providers with the 
requisite knowledge, expertise, and experience in the care of children with diabetes is 
another major issue where the facilities are available; there is lack of basic diagnostic and 
monitoring tools as well as irregular supply of insulin. Insulin is still not available on an 
uninterrupted basis in many parts of the developing world [15]. The prognosis is likely to be 
poor for patients with type 1 diabetes in sub-Saharan Africa and only wealthy patients own 
their own glucose meter. Some patients have their glucose concentrations monitored 
without charge in public health facilities. Patients with comorbidity with diabetes is 
associated with considerable consequences for health care and related costs and comorbidity 
has been shown to intensify utilization of health care facilities and to increase medical care 
costs on patients with diabetes [51].  
3.4. Use of alternative and complementary therapy 
There are many forms of treatment in the African region. Most of the time, the patients visits 
the local traditional healers before coming to the hospital [4]. Traditional healers are an 
integral part of the health care system [37]. Many traditional healers had heard of diabetes 
and knew at least the disease was characterised by excessive thirst and urination[37]. 
Traditional medicine or complementary and / or alternative medicine (CAM) refers to health 
practices, approaches, knowledge and beliefs incorporating plant, animal and mineral based 
medicines, spiritual therapies, manual techniques and exercises applied singularly or in 
combination to treat, diagnose and prevent illness or maintain well being [52], [53]. It 
describes a diverse group of medical and health care system practices and products not 
currently considered an integral part of conventional medicine [3], [54], [55] and are 
consequently not taught as part of the medical curriculum [56]. Traditional medicine is often 
referred to as complementary therapy when used in combination with orthodox medicine 
and alternative therapy when used in place of orthodox medicine [54], [57]. CAM is also 
referred to as holistic or integrative and describes a heterogeneous collection of non-
traditional therapies from chemical substances to prayer [58]. The frequency of utilization of 
CAM is increasing worldwide and is well documented in both African and global 
populations to be between 20 to 80%[56]. In chronic conditions in which health outcomes are 
closely linked to adherence to treatment in which diabetes mellitus is one of them, the use of 
CAM may potentially adversely affect outcome. Multiple therapy practices involving 
combined use of CAM particularly herbal medicines and prescription medications has also 
been identified as being prevalent in some populations. Many herbal remedies have not 
undergone careful scientific assessment and some have the potential to cause serious toxic 
effects and major drug-to-drug interactions. Cultural and economic reasons are largely 
responsible for use of CAM [56]. Researchers have given several reasons for the increased 
prevalence of CAM utilization. These include failure of modern medicine to cure the 
underlying problem and the perception that CAM is cheaper than conventional medicine. In 
countries like Nigeria, possible reasons for the use of CAM include the strong advertisement 
by alternative practitioners that CAM is a panacea to all diseases thus encouraging patients 
to try them. Another possible explanation is the cultural beliefs of Africans that illnesses 
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have a spiritual origin. Patients are thus interested in finding an explanation for their 
symptoms or the root cause of their problems and therefore consult with alternative 
practitioners. In Nigeria, the use of herbal remedies are perceived to be cheaper, may be on 
the increase due to the poor economic state and the increasing costs of orthodox medicines 
also cultural and economic reasons are largely responsible for the use of CAM [56]. The use 
of alternative therapy has become more popular in both developed and developing 
countries in recent times [56]. There advertising strategies on the media and especially using 
vehicles with megaphone from one neighbourhood to another, which do not necessarily 
inform but persuade customers, have also made the use more popular [57]. CAM is 
increasingly used in adults and children [59]. Over 80% of the populations in some African 
and Asian countries depend on traditional medicine for primary health care [60]. The use of 
CAM among diabetics is common [53], [55]. Although some of those therapies may be 
effective, others can be ineffective or even harmful. Patients who use CAM should keep 
their health care providers informed [55]. West Indians Africans, Indians, Latin Americans, 
and Asians mostly use CAM [54]. Prayer, acupunction, massage, hot tub therapy, 
biofeedback, and yoga have been used as well as various plant remedies for treating 
diabetes [54]. Several CAM practices and herbal remedies are promising for diabetes 
treatment but further vigorous study is needed in order to establish safety, efficacy, and 
mechanism of action because many patients with diabetes may be using CAM and to 
consider potential interactions with conventional medicines being used [54]. The increasing 
cost and distrust of modern western medical care in recent years has promoted the use of 
alternative and traditional therapies and has attracted the interest of health professionals, 
researchers, government, and policy makers. The use of CAM has not been limited to 
resource poor settings alone but also among the elites. Claims and refutations by various 
individuals and professional groups of cure for chronic ailments with alternative therapy 
have been reported. Furthermore, inadequate access to modern health care services and a 
trend towards naturalness have strengthened the shift to alternative therapy. The 
unregulated or inappropriate use of alternative therapy has also been documented to have 
negative effects on its users. Alternative therapy medications are not so regulated in most 
countries. There is increased acceptance and use of traditional medicines in recent times 
[57].  
Globally, people developed unique indigenous healing traditions adapted and defined by 
their culture, beliefs and environmental which dissatisfied the health needs of their 
communities over centuries. Over 80% of the population in some Asian and African 
countries depend on traditional medicine for primary health care [2]. Herbal medicine is an 
integral part of traditional medicine and traditional medicine has a broad range of 
characteristic and elements, which earned it the working definition from the World Health 
Organization. Traditional medicines are diverse health practices, approaches, knowledge an 
beliefs that incorporated plant, animal and/ or mineral based medicines, spiritual therapies, 
manual techniques, and exercise, which applied singularly or in combination to maintain 
wellbeing as well as treatment, diagnosis or prevent illness. In a study in Lagos, Nigeria, 
16.2% of respondents’ use herbal medicine to decrease blood sugar [52]. Some other 
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attractions to alternative therapies may be related to the power of the underlying 
philosophies they share, which involve closeness to nature, spirituality and the fact that 
these therapies often go along with the cultural beliefs of the people [61], [62]. In another 
Nigerian study, 46% of diabetics used herbal medicine [63]. CAM is an emerging aspect of 
the management of chronic disease worldwide. The main forms of CAM usage in diabetes 
mellitus include bitter leaf vernonia amygdalina, aloe Vera, garlic, ginger and local herbs. 
There is an increasing use of CAM in diabetes mellitus and this cut across the two main 
types of diabetes mellitus as CAM usage has been reported in type 1 and 2 diabetes mellitus. 
In the African setting for most chronic ailment there are often underlying explanations, 
which are founded on cultural and spiritual beliefs thus, necessitating the use of traditional 
medicines, which are of herbal nature. Of increasing importance in the Nigerian scenario is 
the use and claim of the glucose lowering effects of bitter leaf vernonia amygdalina. This is a 
small shrub with a dark green stem that grows widely in tropical and subtropical Africa and 
is widely used for its medicinal properties. One reason commonly adduced for its usage 
stems from the fact that it is bitter tasting and thus is able to neutralize the sweetness present 
in the blood of people with diabetes mellitus. Use of CAM is suggested by well meaning 
family members or neighbours or other people that had diabetes mellitus and used.  
4. Case series 
4.1. Case 1 
A 42-year-old woman a known diabetic of three years went to seek spiritual help for her 
ailment at a spiritual healing home in Nigeria. She was told to observe a seven days fasting 
with some herbal concoction. On the fifth day of the fasting programme, she went comatose 
and was rushed to the hospital. Her blood sugar was 42 mmol/l with ketones in urinalysis, 
foul smelling breath. The electrolytes, urea, and creatinine were deranged. Respiratory rate 
was 40 breaths/minute, pulse rate 120 beats/minutes, pale, anicteric, afebrile, and 
dehydrated. Blood pressure was 90/40 mmhg. A diagnosis of diabetic ketoacidosis was 
made. She was placed on intravenous ampiclox, metronidazole, intravenous access was 
established, and normal saline set up and Insulin therapy commenced, the blood pressure, 
pulse rate and respiratory rate was measured every 30 minutes. She was managed and 
recovered consciousness two days later. 
Case discussion: Use of alternative therapy is common in Nigeria and other African 
countries. Most of the components of these herbal remedies are not known therefore if it 
contains dangerous toxic substances that can have negative effects on the patient as seen in 
case 1. 
4.2. Case 2 
A 64-year-old man not a known diabetic presented with two weeks history of pains, 
swelling and sore on the right leg. At the onset of the illness, the patient applied several 
herbs on the leg, which started with severe pains and swellings, burst and gave rise to the 
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swelling. On presentation he was ill looking, conscious, and alert, blood pressure 120/70 
mmhg, pulse rate 100 beats /minute, pale, dehydrated with a sore on the right shin, which 
was discharging foul smelling substance. The leg was gangrenous. Haemoglobin 
concentration was 7%, electrolytes, urea, and creatinine where within normal ranges, 
random blood sugar was 36 mmol/l. On urinalysis there was glucose +++ in urine. A 
diagnosis of diabetic foot was made. The patient was placed on subcutaneous soluble 
insulin, haematinics, intravenous antibiotics, and analgesics. Wound swab microscopy, 
culture, and sensitivity were done. He was counselled for below knee amputation and to 
provide two units of blood as blood products where not available at the centre. He said he 
should be given time to think about the amputation. In the evening, he attempted suicide 
when his wife who raised alarm stopped him. He became depressed but later gave consent 
and the amputation was done. 
Case 2 discussion: Diabetic foot results in a large increase in the use of general practice care 
and in the use of medical specialist care and hospital care [51]. This is the case in developing 
countries where most of the populace are poor and do not have assess to quality medical 
care. There are also limited specialist doctors. Patients with diabetes do not only have 
diabetes related co-morbidity but also have non-diabetes related co-morbidity such as 
depression and musculoskeletal diseases [51]. Depression can progress to attempted and 
actual suicide especially when an arm or limb needs to be amputated. Individuals with type 
2 diabetes mellitus are known to have a higher prevalence of depression [63]. Depression is 
common in patients with diabetes mellitus [64]. Diabetes may increase risk of depression 
because of the sense of threat and loss associated with receiving this diagnosis and the 
substantial lifestyle changes necessary to avoid developing debilitating complications [65]. 
Patients with diabetes are more likely to experience depression than the general population 
and the presence of depression is associated with poor quality of life, increase in 
hyperglycaemia, health care utilization, risk of complications, functional impairment, and 
risk of mortality. The relationship between depression and worst outcomes in diabetes 
could be explained in part through depression relationship to poorer self-care and treatment 
adherence [66]. The patient was not depressed or attempted suicide until he was counselled 
for amputation. Amputation is the removal of a body extremity by trauma or surgery. As a 
surgical measure, it is used to control pain or a disease process in the affected limb such as 
malignancy or gangrene. The prevalence of depression is roughly twice as high among 
diabetic patients as among the general population. Depressed patients with diabetes have 
poorer glycaemic control, more severe diabetes symptoms and disability, added 
complications and higher health care use relative to patients with diabetes but on depression 
[67]. Psychological problems from limb amputation persistently retard rapid rehabilitation. 
Some diabetic foot ulcer patients shy away from attending the hospital for fear of 
amputation and eventually some of them die due to infections [68]. 
4.3. Case 3 
A 49-year-old man known diabetic for more than two years with poor drug compliance on 
oral hypoglycaemic agents presented with complaints of fever, vomiting, polydipsia, 
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weakness, and anorexia. A thorn pierced the big toe at the farm of two weeks prior to 
presentation. There was no feeling of pain at the time of impact and an ulcer developed after 
one week, which was worsening and not healing. The ulcer started discharging purulent 
fluid. He is a known hypertensive of five years duration not compliant with medications. 
On examination the patient was febrile temperature 38 [0] C, dehydrated, ill looking with 
periorbital oedema. There was right foot swelling with hypopigmentation, the right big toe 
was gangrenous and tied with a dirty bandage. Haemoglobin estimation was 10%. 
Electrolytes, urea, and creatinine were deranged. A diagnosis of diabetic nephropathy with 
diabetic foot was made. The patient was counselled for disarticulation of the big toe and was 
referred to a tertiary centre for possible dialysis and expert management. 
Case 3 discussion: Diabetes mellitus is a chronic disease with a long-term macrovascular 
and microvascular complications including diabetic nephropathy, neuropathy and 
retinopathy [1]. Macrovascular complications such as stroke, heart disease, peripheral 
vascular disease and foot problems. Miocrovascular complications are diabetic eye diseases 
(retinopathy and cataracts), renal disease, erectile dysfunction, and peripheral neuropathy 
[68]. From various African studies, clinical diabetic nephropathy in Sudan 11.6% [69], 19% in 
1971 in Nigeria [70], 46% in Kenya [71] and 6% in Ethiopia [72]. The exact cause of diabetic 
induced complications are not fully understood, the underlying factor that appears to make 
those with diabetes more prone to many health problems is prolonged and frequently 
elevation of blood sugar [14]. Diabetes mellitus is a complex metabolic disease that can have 
devastating effects on multiple organs in the body. It is the leading cause of end stage renal 
disease in the United States of America and is a common cause of vision loss, neuropathy, 
and cardiovascular diseases [73]. One of the most potentially serious complications regards 
neuropathy is when it is most severe can lead to amputation [74]. The effects of diabetes 
mellitus include long-term damage, dysfunction, and failure of various organs including the 
kidneys [69]. The prevalence of clinical nephropathy has been reported to be between 15 % 
and 40% generally in the developed countries [72].  
4.4. Case 4 
A 62-year-old woman known diabetic of eight years duration presented with injury to her 
left big toe after placing it over a hot object, which she did not know she stepped on a hot 
object. The toe was already gangrenous at the time of presentation. She had a right above 
knee amputation two years prior to presentation for gangrenous diabetic foot. She was 
counselled for disarticulation of the left toe. She refused and signed against medical advice.  
Case 4 Discussion: Diabetes is an important cause of amputation of the lower limb resulting 
from of non-traumatic origin as well as blindness and kidney failure. Problems of the foot 
are the most frequent reason for hospitalization amongst patients who have diabetes. Many 
hospital visits due to diabetes related foot problems are preventable through simple foot 
care routine. Amongst people who have diabetes, amputations are reported to be 15 times 
more common than amongst other people. 50% of all amputations occur in people who have 
diabetes [74]. Diabetic ulcers are the most common foot lesions leading to lower extremity 
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amputation [68]. Management of the diabetic foot requires a thorough knowledge of the 
major risk factors for amputation, frequent routine evaluation, and preventive maintenance. 
The aetiology of lower extremity diabetic ulcer includes injury complicated by underlying 
neuropathy, ischemia, or both [68]. Lower limb amputation remains one of the commonest 
surgical procedures. In a ten-year review from 1997-2006 of lower limb amputation at a 
Nigerian private tertiary hospital, 64 amputations were done due to gangrenous diabetic 
foot [75]. Foot lesions cause pain, morbidity, have substantial economic consequences beside 
the direct costs relating to loss of productivity, individual patients and family costs and loss 
of health related quality of life. The lifetime risk of a person with diabetes developing a foot 
ulcer could be as high as 25% and it is believed that every 30 seconds a lower limb is lost 
somewhere in the world because of diabetes. People with diabetes are prone to developing 
foot ulcer amputation and other lower extremity. Diabetic foot problems are a common 
occurrence throughout the world, resulting in major economic consequences for patients, 
their families, and society. Because foot ulcer are most likely to be of neuropathic origin they 
are eminently preventable in the developing countries that will experience the greatest 
increase in the prevalence of type 2 diabetes in the next 20 years [76]. People at the greatest 
risk of the ulceration can easily be identified by careful examination of the feet, education 
and frequent follow up is indicated in these patients [76]. Diabetic foot complications 
constitute an increased public health problem and are a leading cause of admission, 
amputation, and mortality in diabetic patients and yet since neuropathy is the major cause, 
they should be in many cases preventable. Early diagnosis, education, and treatment are 
crucial. Diabetic foot problem are common all over the globe and have major economic 
consequences to society, diabetic patients and their families [76]. The recurrence rates of foot 
ulcers are > 50% after 3 years, an important thing to remember when assessing the economic 
impact of diabetic foot disease. Cost of diabetic foot diseases therefore includes not only the 
immediate episode but also social services home care and subsequent ulcers [76]. Diabetic 
foot ulcers are associated with significant morbidity and mortality in individuals with 
diabetes mellitus. Diabetic foot ulcer is the leading cause of non-traumatic lower extremity 
amputations worldwide. Preceding events of diabetic foot ulcers include trauma, wearing 
ill-fitting shoes and burns [77]. When foot ulceration presents late and is most frequently 
associated with neuropathy and infections. The region of sub-Saharan Africa contains 33 of 
the 50 poorest countries in the world and will experience the greatest risk in the prevalence 
of diabetes over the next 20 years. Diabetic foot complications constitute an increasing 
public health problem and are a leading cause of admission, amputation and mortality in 
diabetic patients and yet since neuropathy is the major cause, they should been many cases 
preventable. Early diagnosis, education, and treatment are crucial. Educational programs 
must meet the specific needs of the patient, understanding their social background. An 
integrated approach to foot care can improve patients’ outcomes even in rural areas. A 
review of the epidemiology of diabetic foot problems in Africa highlighted not only the 
frequency of neuropathy but also the increasing frequency of peripheral vascular disease, 
presumably in result of increasing urbanization. Diabetic foot is the most frequent cause of 
prolonged hospital admission in diabetic patients and is significantly a contributor to the 
considerable morbidity associated with the diabetic foot. Foot complications in Africa are 
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mainly because of infection in the neuropathic foot rather than due to peripheral vascular 
disease. Although neuropathy is often the initiating factor for foot ulceration, ischemia is 
critically important in determining healing despite a relative low prevalence rate of 
peripheral vascular disease in diabetic patients with foot ulcers in Africa; amputation is a 
frequent outcome mainly due to uncontrolled infection. Several factors have been identified 
as greatly increasing the risk factors of neuropathy. Poverty and barefoot walking, 
inappropriate footwear, poor foot hygiene and delay in seeking medical attention [78].  
Diabetic foot ulcers are estimated to affect 15% of all diabetics during their lifetime and 
precede almost 85% of all amputations. Diabetes by virtues of its complications like 
neuropathy and vasculopathy and other factors affect the musculoskeletal and soft tissue 
mechanics in a manner that elevates planter pressure and makes tissue damage more likely, 
causing non-resolving neuroischeamic ulcers at the weight bearing sites [79]. There is rising 
incidence of diabetic foot in Nigeria, which has recently become an important indication for 
lower limb amputation in Nigeria [80]. In a 15-year review in Nigeria, amputation following 
diabetic foot was the third indication of amputation 12.3% of diabetic gangrene [81]. 
Diabetics undergoing surgery belong to the high-risk group of patients. The risks are worst 
in the presence of severe complications such as diabetic foot gangrene. Foot problems are a 
major cause of hospital bed occupancy by diabetic patients. Early counselling and 
psychotherapy are necessary to avoid delayed consent for amputation [50]. Factors 
associated with poor outcomes include delays in seeking medical attention and ulcers that 
have progressed to gangrene at the time of presentation. In Africa, foot complications are 
the main cause of prolonged hospital stays for people with diabetes and are associated with 
substantial mortality, constituting a major public health problem[49]. In Tanzania, the 
highest mortality rates are observed in people with severe gangrenous ulcers not treated 
with aggressive surgery. Diabetic foot infection is a limb threatening complications and 
several studies have shown it to be the immediate cause of amputation in 25-50% of people 
with diabetes [49]. In sub-Saharan Africa, peripheral neuropathy is the principal underlying 
risk factor in the pathogenesis of foot ulcers in people with diabetes [49]. Foot infections 
usually begin in foot ulcers that are sequalae of existing neuropathy, macrovascular 
diseases, or certain metabolic disturbances. Risks of infection are exacerbated by the 
decrease in cellular immunity caused by acute hyperglycaemia and circulatory deficits 
caused by chronic hyperglycaemia. Diabetic foot infection is a limb threatening complication 
and several studies have shown it to be the immediate cause of amputation in 25-50% of 
people with diabetes [49]. In developing countries, increasing prevalence of diabetes and 
emergence of resistant strains of bacteria are among several factors related complications to 
the burden of infection related complications. Infection complications are noted among the 
commonest surgical presentations in diabetes foot. The diabetic patient has a greater 
susceptibility to infections that arise from several aspects of an altered immunity foot 
infections are a common problem in developing countries where diabetes mellitus is an 
emerging problem. The high incidence of undiagnosed diabetics poses a major public health 
challenge in developing countries. Amputations remain one of the key indications of severe 
diabetic foot disease. 
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5. Conclusion 
Diabetes mellitus is a public health problem in developing countries and education should 
be a high priority intervention for all developing regions. Proper education regarding 
footwear and foot care is necessary in diabetics. 
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